16.98
Spyre Therapeutics Inc (SYRE) 最新ニュース
Market reaction to Spyre Therapeutics Inc.’s recent newsConservative Asset Allocation Risk Analysis - Newser
Identifying reversal signals in Spyre Therapeutics Inc.RSI and MACD Signal Summary with Trends - Newser
What are the technical indicators suggesting about Spyre Therapeutics Inc.Post Market Opportunities For Consistent Profits - jammulinksnews.com
Victory Capital Management Inc. Sells 16,230 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World
How Resilient Is Spyre Therapeutics Inc. Stock During Economic Downturns AI Trading Forecast Based on Big Data - Newser
Moving Average Trends for Spyre Therapeutics Inc. Stock: What They Indicate Real Time Growth Signal with Smart Setup - Newser
Market reaction to Spyre Therapeutics Inc.’s recent news Free Quick Gain Stock Watch With Indicators - Metal.it
How to track smart money flows in Spyre Therapeutics Inc. Free Low Volatility Stable Growth Picks - Newser
What makes Spyre Therapeutics Inc. stock price move sharplyGet real-time alerts on top stocks - jammulinksnews.com
How volatile is Spyre Therapeutics Inc. stock compared to the marketExplosive trading growth - jammulinksnews.com
How does Spyre Therapeutics Inc. compare to its industry peersInvest confidently with advanced analysis tools - jammulinksnews.com
How Resilient Is Spyre Therapeutics Inc. Stock During Economic DownturnsFree Exclusive Investment Tips - Newser
Why Spyre Therapeutics Inc. stock attracts strong analyst attentionFree Membership Group - Metal.it
Will Spyre Therapeutics Inc. stock benefit from AI tech trendsTriple-digit returns - jammulinksnews.com
Is Spyre Therapeutics Inc. a good long term investmentHigh-impact stock picks - PrintWeekIndia
Spyre Therapeutics Inc. Stock Analysis and ForecastFree Investment Risk Control - PrintWeekIndia
What analysts say about Spyre Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
This Spyre Therapeutics Insider Reduced Their Stake By 55% - 富途牛牛
What drives Spyre Therapeutics Inc. stock priceRapid capital growth - jammulinksnews.com
Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Target Price at $53.40 - Defense World
How Spyre Therapeutics Inc. stock performs during market volatilityPredictable High Return Trades - Newser
Here's Why We're Not Too Worried About Spyre Therapeutics' (NASDAQ:SYRE) Cash Burn Situation - Yahoo Finance
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
大文字化:
|
ボリューム (24 時間):